![3-chloro-5-(3-chloropropyl)-10,11-dihydro-5H-dibenzo[b,f]azepine](https://static.cymitquimica.com/cas-image/196044-3-chloro-5-3-chloropropyl-1011-dihydro-5h-dibenzo-b-f-azepine.png)
CAS: 51551-41-8 - 3-chloro-5-(3-chloropropyl)-10,11-dihydro-5H-dibenzo[b,f]azepine
Formel:C17H17Cl2N
InChl:InChI=1/C17H17Cl2N/c18-10-3-11-20-16-5-2-1-4-13(16)6-7-14-8-9-15(19)12-17(14)20/h1-2,4-5,8-9,12H,3,6-7,10-11H2
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | 3-Chloro-5-(3-chloropropyl)-10,11-dihydro-5H-dibenz[b,f]azepine (>90%) REF: TR-C365075CAS: 51551-41-8 | >90% | 168,00 €~1.217,00 € | Mo 28 Okt 24 |
 | 3-Chloro-5-(3-chloropropyl)-10,11-dihydro-5H-dibenz[b,f]azepine REF: 3D-FC20114CAS: 51551-41-8 | 90%Min | 136,00 €~711,00 € | Fr 29 Nov 24 |
![3-Chloro-5-(3-chloropropyl)-10,11-dihydro-5H-dibenz[b,f]azepine (>90%)](https://static.cymitquimica.com/products/TR/thumb/C365075.jpg)
3-Chloro-5-(3-chloropropyl)-10,11-dihydro-5H-dibenz[b,f]azepine (>90%)
Kontrolliertes ProduktCAS:51551-41-8
Applications Clomipramine intermediate as analgesic, antidiabetic and antiinflammatory agent. References Nakanishi, et al.: J. Med. …
Formel:
C17H17Cl2N
Reinheit:
>90%
Farbe und Form:
Neat
Molekulargewicht:
306.23
Ref: TR-C365075
| 1g | 1.217,00 € | ||
| 100mg | 168,00 € | ||
| 500mg | 706,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Montag 28. Oktober 2024
![3-Chloro-5-(3-chloropropyl)-10,11-dihydro-5H-dibenz[b,f]azepine](https://static.cymitquimica.com/products/3D/thumb/FC20114.jpg)
3-Chloro-5-(3-chloropropyl)-10,11-dihydro-5H-dibenz[b,f]azepine
CAS:51551-41-8
Please enquire for more information about 3-Chloro-5-(3-chloropropyl)-10,11-dihydro-5H-dibenz[b,f]azepine including the price, delivery time and more detailed …
Formel:
C17H17Cl2N
Reinheit:
90%Min
Molekulargewicht:
306.23 g/mol
Ref: 3D-FC20114
| 10mg | 136,00 € | ||
| 25mg | 155,00 € | ||
| 50mg | 233,00 € | ||
| 100mg | 364,00 € | ||
| 250mg | 711,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Freitag 29. November 2024
